Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD
Public ClinicalTrials.gov record NCT02633527. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD - A Double-Blind, Placebo-Controlled, Dose-Ranging Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a randomized, double-blind, placebo-controlled, multicenter, 5-arm, parallel-group, dose-ranging study to assess the efficacy and safety of SPN-812 (Viloxazine Extended-release Capsule) in children 6-12 years of age with ADHD.
Study identification
- NCT ID
- NCT02633527
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 222 participants
Conditions and interventions
Interventions
- Placebo Drug
- 100mg SPN-812 Drug
- 200mg SPN-812 Drug
- 300mg SPN-812 Drug
- 400mg SPN-812 Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2016
- Primary completion
- Jul 24, 2016
- Completion
- Jul 24, 2016
- Last update posted
- Oct 26, 2021
2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Florida Clinical Research Center, LLC | Maitland | Florida | 32751 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Attention-Deficit/Hyperactivity Disorder (ADHD) trials
Other public records listing Attention-Deficit/Hyperactivity Disorder (ADHD). Sorted by last update posted; newest first. Not a recommendation.
- NCT07793045: Binaural Beats Stimulation for Adults With ADHD Recruiting
- NCT07654205: Smartphone-based Intervention for Young Adults With ADHD Recruiting
- NCT07226219: Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease Recruiting
- NCT06810180: Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD Recruiting
- NCT06853665: The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine Recruiting
- NCT06960980: Improving ADHD Teen Driving - Virtual Reality Recruiting
All Attention-Deficit/Hyperactivity Disorder (ADHD) trials →
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02633527, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2021 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02633527 live on ClinicalTrials.gov.